Argyle Capital Partners, LLC Bristol Myers Squibb CO Transaction History
Argyle Capital Partners, LLC
- $121 Billion
- Q2 2025
A detailed history of Argyle Capital Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Argyle Capital Partners, LLC holds 9,585 shares of BMY stock, worth $432,666. This represents 0.37% of its overall portfolio holdings.
Number of Shares
9,585
Previous 13,349
28.2%
Holding current value
$432,666
Previous $814 Million
45.5%
% of portfolio
0.37%
Previous 0.7%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,676Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.8 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.16 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.88 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.28 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.2 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...